NovoCure GmbH   Report issue

For profit
Founded: Munich Germany (2000)

Organization Overview

First Clinical Trial
2019
NCT04281576
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

NovoCure GmbH